Literature DB >> 21565331

miR-29c regulates BACE1 protein expression.

Yuanyuan Zong1, Hailin Wang, Wei Dong, XiongZhi Quan, Hua Zhu, YanFeng Xu, Lan Huang, Chunmei Ma, Chuan Qin.   

Abstract

Recently, BACE1 expression was shown to be regulated by microRNAs, small endogenous RNA molecules that regulate protein expression through sequence-specific interaction with messenger RNA. Here, we showed that microRNA-29c (miR-29c), a miRNA that is enriched in the brain and highly expressed in the APPswe/PSΔE9 mouse lowers BACE1 protein in vitro and in transgenic miR-29c mice. In silico analysis identified two putative target sites in the BACE1 mRNA for the miR-29c family. We chose SH-SY5Y, HEK-293T cell lines and miR-29c transgenic mice for these studies to validate our hypothesis. Significantly, over-expression of miR-29c in SH-SY5Y, HEK-293T cell lines and miR-29c transgenic mice downregulated BACE1 protein levels. Our findings suggest that miR-29c may be an endogenous regulator of BACE1 protein expression. Crown
Copyright © 2011. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21565331     DOI: 10.1016/j.brainres.2011.04.035

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  43 in total

1.  miR-186 is decreased in aged brain and suppresses BACE1 expression.

Authors:  Jaekwang Kim; Hyejin Yoon; Dah-Eun Chung; Jennifer L Brown; Krystal C Belmonte; Jungsu Kim
Journal:  J Neurochem       Date:  2016-03-30       Impact factor: 5.372

2.  Assessment of Apoptosis Pathway in Peripheral Blood of Autistic Patients.

Authors:  Mohammad Mahdi Eftekharian; Alireza Komaki; Vahid Kholghi Oskooie; Amir Namvar; Mohammad Taheri; Soudeh Ghafouri-Fard
Journal:  J Mol Neurosci       Date:  2019-07-30       Impact factor: 3.444

3.  Downregulated miR-29c correlates with increased BACE1 expression in sporadic Alzheimer's disease.

Authors:  Xiaofeng Lei; Lijian Lei; Zhelin Zhang; Zhiqing Zhang; Yan Cheng
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

Review 4.  Non-coding RNAs in Alzheimer's disease.

Authors:  Lin Tan; Jin-Tai Yu; Nan Hu; Lan Tan
Journal:  Mol Neurobiol       Date:  2012-10-07       Impact factor: 5.590

Review 5.  MicroRNAs in glaucoma and neurodegenerative diseases.

Authors:  Milena Molasy; Anna Walczak; Jerzy Szaflik; Jacek P Szaflik; Ireneusz Majsterek
Journal:  J Hum Genet       Date:  2016-07-14       Impact factor: 3.172

6.  MicroRNA-339-5p down-regulates protein expression of β-site amyloid precursor protein-cleaving enzyme 1 (BACE1) in human primary brain cultures and is reduced in brain tissue specimens of Alzheimer disease subjects.

Authors:  Justin M Long; Balmiki Ray; Debomoy K Lahiri
Journal:  J Biol Chem       Date:  2013-12-18       Impact factor: 5.157

Review 7.  Epigenetic mechanisms of neurodegenerative diseases and acute brain injury.

Authors:  Mario J Bertogliat; Kahlilia C Morris-Blanco; Raghu Vemuganti
Journal:  Neurochem Int       Date:  2019-12-12       Impact factor: 3.921

Review 8.  miRNAs: Key Players in Neurodegenerative Disorders and Epilepsy.

Authors:  Hanuma Kumar Karnati; Manas Kumar Panigrahi; Ravi Kumar Gutti; Nigel H Greig; Ian A Tamargo
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

9.  Valproate improves memory deficits in an Alzheimer's disease mouse model: investigation of possible mechanisms of action.

Authors:  Zhi-Gang Yao; Liang Liang; Yu Liu; Ling Zhang; Hua Zhu; Lan Huang; Chuan Qin
Journal:  Cell Mol Neurobiol       Date:  2014-06-18       Impact factor: 5.046

10.  miR-98-5p Acts as a Target for Alzheimer's Disease by Regulating Aβ Production Through Modulating SNX6 Expression.

Authors:  Qiushi Li; Xidong Li; Li Wang; Yanhui Zhang; Long Chen
Journal:  J Mol Neurosci       Date:  2016-08-19       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.